SQD Stock Overview
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
SQI Diagnostics Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.015 |
52 Week High | CA$0.17 |
52 Week Low | CA$0.01 |
Beta | 0.075 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -85.71% |
3 Year Change | -93.88% |
5 Year Change | -89.29% |
Change since IPO | -99.23% |
Recent News & Updates
Recent updates
SQI Diagnostics (CVE:SQD) Has Debt But No Earnings; Should You Worry?
Apr 20Is SQI Diagnostics (CVE:SQD) Weighed On By Its Debt Load?
Jul 27Health Check: How Prudently Does SQI Diagnostics (CVE:SQD) Use Debt?
Apr 09Are Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?
Mar 03Is SQI Diagnostics Inc. (CVE:SQD) Popular Amongst Insiders?
Jan 27If You Had Bought SQI Diagnostics (CVE:SQD) Stock A Year Ago, You Could Pocket A 246% Gain Today
Dec 22Is SQI Diagnostics (CVE:SQD) Using Debt Sensibly?
Nov 17Shareholder Returns
SQD | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | 0% | -2.8% | 0.4% |
1Y | -85.7% | -20.7% | 9.0% |
Return vs Industry: SQD underperformed the Canadian Medical Equipment industry which returned -12.6% over the past year.
Return vs Market: SQD underperformed the Canadian Market which returned -0.8% over the past year.
Price Volatility
SQD volatility | |
---|---|
SQD Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 11.9% |
Market Average Movement | 8.5% |
10% most volatile stocks in CA Market | 18.4% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: SQD's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SQD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Andrew Morris | https://www.sqidiagnostics.com |
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow.
SQI Diagnostics Inc. Fundamentals Summary
SQD fundamental statistics | |
---|---|
Market cap | CA$6.11m |
Earnings (TTM) | -CA$19.14m |
Revenue (TTM) | CA$3.05m |
2.0x
P/S Ratio-0.3x
P/E RatioIs SQD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SQD income statement (TTM) | |
---|---|
Revenue | CA$3.05m |
Cost of Revenue | CA$3.19m |
Gross Profit | -CA$140.00k |
Other Expenses | CA$19.00m |
Earnings | -CA$19.14m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.047 |
Gross Margin | -4.60% |
Net Profit Margin | -628.51% |
Debt/Equity Ratio | -103.3% |
How did SQD perform over the long term?
See historical performance and comparison